Expert Interview
Exploring Narcolepsy and the Phase 3 studies FirstLight (TAK-861-3001) and RadiantLight (TAK-861-3002) of Oveporexton by Takeda
Ticker(s): TAKInstitution: Mecklenburg Neurology
- Neurologist and Epileptologist in private practice in Charlotte, NC.
- Manages 20 patients with Narcolepsy and 100 patients with Multiple Sclerosis.
- Utilizes infusion center in practice, with ~50% of patients receiving infusions.
How many patients do you manage with narcolepsy?
Added By: emily_adminOn a scale of 1-10 (with 10 being ecstatic), how excited are you about the potential uses of Oveporexton (TAK-861)?
Added By: emily_adminHow would you plan to incorporate Oveporexton into your treatment algorithm?
Added By: emily_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
